PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 224 filers reported holding PROMETHEUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.71 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,395 | +79.8% | 22,321 | +84.4% | 0.03% | +75.0% |
Q4 2022 | $1,332 | -99.7% | 12,107 | +84.5% | 0.02% | +220.0% |
Q3 2022 | $387,000 | +27.7% | 6,563 | -14.3% | 0.01% | +150.0% |
Q4 2021 | $303,000 | +99.3% | 7,659 | +19.7% | 0.00% | +100.0% |
Q3 2021 | $152,000 | – | 6,396 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 1,848,024 | $198,329,936 | 93.93% |
CHI Advisors LLC | 934,135 | $100,251,367 | 26.61% |
Cormorant Asset Management, LP | 1,655,000 | $177,615 | 11.70% |
Boxer Capital, LLC | 1,897,500 | $203,640 | 10.00% |
RTW INVESTMENTS, LP | 3,272,104 | $351,162,201 | 7.31% |
Decheng Capital Management III (Cayman), LLC | 150,000 | $16,098,000 | 6.50% |
Waypoint Capital Advisors, LLC | 154,466 | $16,577,292 | 5.40% |
Affinity Asset Advisors, LLC | 150,000 | $16,098,000 | 5.31% |
Perceptive Advisors | 1,272,694 | $136,585,520 | 4.03% |
Ikarian Capital, LLC | 125,926 | $13,514,378 | 3.07% |